- Home
- HPE vs BNTX Comparison
HPE vs BNTX Comparison
Compare HPE & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPE
- BNTX
- Stock Information
- Founded
- HPE 1939
- BNTX 2008
- Country
- HPE United States
- BNTX Germany
- Employees
- HPE N/A
- BNTX N/A
- Industry
- HPE Retail: Computer Software & Peripheral Equipment
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HPE Technology
- BNTX Health Care
- Exchange
- HPE Nasdaq
- BNTX Nasdaq
- Market Cap
- HPE 27.4B
- BNTX 23.9B
- IPO Year
- HPE N/A
- BNTX 2019
- Fundamental
- Price
- HPE $23.96
- BNTX $121.72
- Analyst Decision
- HPE Buy
- BNTX Strong Buy
- Analyst Count
- HPE 14
- BNTX 14
- Target Price
- HPE $23.36
- BNTX $141.60
- AVG Volume (30 Days)
- HPE 13.4M
- BNTX 1.1M
- Earning Date
- HPE 12-05-2024
- BNTX 11-04-2024
- Dividend Yield
- HPE 2.17%
- BNTX N/A
- EPS Growth
- HPE 25.32
- BNTX N/A
- EPS
- HPE 1.93
- BNTX N/A
- Revenue
- HPE $30,127,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- HPE $7.79
- BNTX N/A
- Revenue Next Year
- HPE $4.16
- BNTX N/A
- P/E Ratio
- HPE $12.41
- BNTX N/A
- Revenue Growth
- HPE 3.40
- BNTX N/A
- 52 Week Low
- HPE $14.47
- BNTX $76.53
- 52 Week High
- HPE $24.24
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- HPE 71.05
- BNTX 60.69
- Support Level
- HPE $20.96
- BNTX $112.96
- Resistance Level
- HPE $21.60
- BNTX $121.80
- Average True Range (ATR)
- HPE 0.70
- BNTX 5.01
- MACD
- HPE 0.09
- BNTX 1.07
- Stochastic Oscillator
- HPE 92.23
- BNTX 86.57
About HPE Hewlett Packard Enterprise Company
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment; it also has a high-performance computing business. HPE's stated goal is to be a complete edge-to-cloud company, and its portfolio enables hybrid clouds and hyperconverged infrastructure. It uses a primarily outsourced manufacturing model and employs 60,000 people worldwide.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.